Galaxy Therapeutics INC
Undisclosed program
Intracranial Aneurysm
Countdown
66days
Phase 3 readout · Sep 10, 2026
What's at stake
Phase 3 trial results for Undisclosed program in Intracranial Aneurysm are due Sep 10, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· ClinicalTrials.gov
verified 13h ago
“CT.gov NCT05831202: Phase 3 trial, sponsor Galaxy Therapeutics INC. Primary completion date 2026-09-10 (estimated).”